Alto Neuroscience’s Post

🧠 Scripps Research scientists have identified a set of neurons in the parasubthalamic nucleus that influence the start of eating and drinking. Their groundbreaking study, published in Molecular Psychiatry, shows how activating these neurons can delay the first bite of food but prompt faster water intake in mice. This discovery sheds light on the intricate brain mechanisms involved in hunger-driven decision-making and could have implications for understanding and managing eating disorders. Dive into the details of how the brain controls our earliest impulses to eat or drink! #Neuroscience #EatingBehavior #ScrippsResearch #ResearchInnovation Read more: https://lnkd.in/eG53sHgC

Thank you to all who attended yesterday's presentation, ‘Translations in clinical neuroscience,’ by our CEO Professor Matthew Kiernan AM, hosted at NeuRA. Professor Kiernan discussed the latest advancements in human brain function, signal transmission and the promising future of neurological treatments. We also wish to acknowledge the Discipline of Psychiatry and Mental Health, UNSW Medicine & Health, for organising and promoting this event as part of their Research Seminar series. #neuroscience #clinicalresearch #precisionmedicine

Original knowledge regarding human brain function was largely derived from cellular and animal models. However, the advent of technological advances has led to new concepts in the understanding of signal transmission and brain information processing. This new molecular understanding of the human nervous system, combined with rapid developments across medical imaging technologies has promoted an understanding of the inner workings of the brain and its role in determining behaviour, in addition to tracking plastic change following injury and disease. Presently, there is an unprecedented number of treatments now being introduced to neurological practice. To facilitate progress, there remains a need to expand clinical trial development through establishment of national clinical trials facilities; and to understand the impact of treatments on patients. In time, the introduction of precision medicine will become commonplace in clinical practice, further promoting a therapeutic era.

#HOT about the human #brain 🧠 in the #NEWS 🗞 🧠 Human Brain Matter 🧠 "A new, theory-driven, clinically validated and interpretable quantitative method to parse the biological heterogeneity of depression and anxiety. They represent a promising approach to advance precision clinical care in psychiatry". "Task-free and task-evoked data from a standardized functional magnetic resonance imaging protocol conducted across multiple studies in patients with depression and anxiety when treatment free (n = 801) and after randomization to pharmacotherapy or behavioral therapy (n = 250) were used. From these patients, personalized and interpretable scores of brain circuit dysfunction grounded in a theoretical taxonomy were derived. Participants were subdivided into six biotypes defined by distinct profiles of intrinsic task-free functional connectivity within the default mode, salience and frontoparietal attention circuits, and of activation and connectivity within frontal and subcortical regions elicited by emotional and cognitive tasks". __ #mentalhealth #brain #health #wellness #humanity #neuroscience #medicine #longivity #HBE #humanbrainexpo #3hbrain #science #AI #brainhealth #ethics #helpfulbrain #innovation #innovationmanagement #events #news #biotech #psychiatry https://lnkd.in/gNBNNVv3

🧠 Celebrating a Century of EEG: From Hans Berger's Discovery to Modern Breakthroughs in Mental Health 🧠 For the past 100 years, EEG technology has revolutionized our understanding of the brain, offering invaluable insights in both research and clinical practice. From its origins with Hans Berger's first recordings in 1924 to its present-day applications in psychiatry and neurology, EEG has evolved significantly. At neurocare, we are proud to continue this legacy, advancing QEEG and Neurofeedback to empower clinicians with cutting-edge tools for personalized mental health care. Explore how EEG is shaping the future of psychiatry and psychology. In this article, we speak with neurocare's in-house EEG and Neurofeedback experts Klaus Schellhorn, Trevor Brown, Amna Ghani, and Hartmut Heinrich, who share their insights in the field. 🔗 See the link in the comments to read the article. #neurocare #neurocaregroup #Neuroscience #MentalHealth #Innovation #EEG #Neurofeedback 

“I got into neuroscience to find answers for my patients. Now, as a scientist I realize the questions to ask are even more complex.” - Nathalia Cardozo Da Conceicao, PhD-fellow at BRIC. It is #brainawarenessweek, and to honor research in the brain and #neurobiology we share our enthusiasm on the brain and on brain science. Nathalia Cardozo has crossed the line from being a medical doctor and psychiatrist to be a PhD Fellow at BRIC in Khodosevich group. By bridging the gap between clinic and research, she hopes to bring knowledge back to clinical practice and make an even bigger difference for patients than before. “When I was working as a psychiatrist, patients often asked many questions on the reasons behind the disorders. I wanted to answer their questions, but there is still a lot that has not yet been discovered in psychiatry. Now, I work looking for clues on the mechanisms of psychiatric disorders and I ask even more complex questions. As a scientist you must be curious, work to understand and ultimately make a treatment. I got into psychiatry to help patients. As a scientist I can help on a bigger scale by bridging the knowledge between clinic and science.” During Brain Awareness Week five researchers from BRIC will share their enthusiasm on the brain. #brainweek #brainawarenessweek #brainhealth #neuroscience #neurobilogy #brainawarenessweek2024

#NeuroScience | 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗻𝗴 𝗣𝘀𝘆𝗰𝗵𝗼𝘀𝗶𝘀 | Researchers at the University of Geneva, led by Professor Stephan Eliez from the Department of Psychiatry, have made a significant breakthrough in the potential prediction of psychosis. Their study explores the use of brain structure and function to assess the developmental trajectory of individuals, aiming to identify those at risk of developing psychiatric illnesses. Funded by the Swiss National Science Foundation SNSF, this groundbreaking research combined observations of both the brain’s structure and its functional synchronization. This methodological innovation could pave the way for early identification and intervention for those susceptible to psychosis, offering new insights into the mechanisms underpinning psychiatric disorders. 👉 Learn more >> https://lnkd.in/eXBaa4UY 👉 Original publication >> https://lnkd.in/eDVGwVzG Image: UNIGE / Eliez 🇨🇭 Follow #ScienceSwitzerland for the latest news and emerging trends on Swiss science, technology, education, and innovation >> www.swissinnovation.org Follow us >> Science-Switzerland #Science | #Education | #Research | #Innovation

📄NEW PUBLICATION | "Structural brain differences in the Alzheimer’s disease continuum: Insights into the heterogeneity from a large multi-site neuroimaging consortium" in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging with the participation of some LAC-CD members. A study of more than 27,000 subjects from international datasets reveals how record diversity-especially ethnicity-improves our understanding of Alzheimer's progression through neuroimaging. Access the paper here 👉 https://t.ly/cwP3o Universidad Adolfo Ibáñez BrainLat UAI Universidad de San Andrés Centro de Neurociencias Cognitivas GERO CHILE Global Brain Health Institute (GBHI) Atlantic Fellows Trinity College Dublin ReDLat Dementia

🔬 New Research Publication: Journal of Neuro Psychiatry Reports 📚 We’re excited to share our latest review article, now published and open access by MLS academy and a special thanks for Dr. Hiba Hamdar Title: Antidepressant Role in Modulating Neurotransmitter Imbalance to Improve Cognitive Impairment in Alzheimer’s Disease This publication explores the complex interplay between neurotransmitter dysregulation and antidepressant therapy in Alzheimer’s disease, emphasizing the potential of antidepressants to improve cognitive function through neurogenesis stimulation and increased levels of brain-derived neurotrophic factor (BDNF). Key findings highlight the importance of antidepressants in reducing amyloid plaques and tau phosphorylation, offering novel insights into Alzheimer’s treatment strategies. Access the full article: https://lnkd.in/ep8JFuNa Thanks for the authors: Hawraa Tofaili , Kholoud AL Jebawi , Hiba Hamdar , Nourhan Kanso and others #AlzheimersResearch #Neuroscience #Antidepressants #CognitiveImprovement #OpenAccess #research

Starting from the basics of Evolutionary Psychiatry, watch Dr Bhaskar Mukherjee talk about how and why we develop hallucinations and delusions. In this wide ranging discussion, we use a blackboard to illustrate and discuss the relevant pathways and talk about molecular neuroscience, which forms the basic building blocks of our cognition and perception of reality. https://lnkd.in/ePwmcbw4